Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (271-280 of 339) with videos related to

Pageof 34
Sort By:
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Blood Advances|November 19, 2019
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysisKathy L McGraw, Chia-Ho Cheng, Y Ann Chen, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Communications|June 30, 2022
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational statePeter G Miller, Murugappan Sathappa, Jamie A Moroco, et al.
Blood|May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasmsAdam S Sperling, Veronica A Guerra, James A Kennedy, et al.
Elife|February 9, 2017
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerabilityBrenton R Paolella, William J Gibson, Laura M Urbanski, et al.
Journal of the American College of Cardiology|July 2, 2021
Supplemental Association of Clonal Hematopoiesis With Incident Heart FailureBing Yu, Mary B Roberts, Laura M Raffield, et al.
Blood Advances|January 11, 2022
Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansionUrsula S A Stalmann, Fabio Ticconi, Inge A M Snoeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Pageof 34

Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Blood Advances|November 19, 2019
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysisKathy L McGraw, Chia-Ho Cheng, Y Ann Chen, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Communications|June 30, 2022
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational statePeter G Miller, Murugappan Sathappa, Jamie A Moroco, et al.
Blood|May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasmsAdam S Sperling, Veronica A Guerra, James A Kennedy, et al.
Elife|February 9, 2017
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerabilityBrenton R Paolella, William J Gibson, Laura M Urbanski, et al.
Journal of the American College of Cardiology|July 2, 2021
Supplemental Association of Clonal Hematopoiesis With Incident Heart FailureBing Yu, Mary B Roberts, Laura M Raffield, et al.
Blood Advances|January 11, 2022
Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansionUrsula S A Stalmann, Fabio Ticconi, Inge A M Snoeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Pageof 34